Di Gian (Robert) v. Clinton (William), 6 F.3d 778 (3rd Cir. 1993). · Go Syfert
Di Gian (Robert) v. Clinton (William), 6 F.3d 778 (3rd Cir. 1993). Cases Citing This Book View Copy Cite
67 citation events (14 in the last 25 years) across 24 distinct courts.
Strongest positive: Merrell Dow Pharmaceuticals, Inc. v. Havner (tex, 1997-11-13)
Treatment trajectory · 1993 → 2026 · click a year to view as-of
1993 2009 2026
Top citers, strongest first. 11 distinct citers. How cited ↗
discussed Cited "see" Merrell Dow Pharmaceuticals, Inc. v. Havner (2×)
Tex. · 1997 · signal: see · confidence high
See DeLuca v. Merrell Dow Pharms., Inc., 791 F.Supp. 1042, 1046 (D.N.J.1992), aff'd, 6 F.3d 778 (3d Cir.1993); Bailey et al., Reference Guide on Epidemiology, in Reference Manual on Scientific Evidence, supra, at 153; Dore, A Proposed Standard, supra note 3, 28 How.
discussed Cited "see" Rutigliano v. Valley Business Forms
D.N.J. · 1996 · signal: see · confidence high
See DeLuca by DeLuca v. Merrell Dow Pharmaceuticals, Inc., 911 F.2d 941, 958 (3d Cir.1990) (testimony must be able to support a jury finding both (i) that the drug can produce birth defects and (ii) that the drug more likely than not caused the birth defects in this particular case), on remand 791 F.Supp. 1042 (D.N.J.1992), aff'd, 6 F.3d 778 (3d Cir.1993), cert. denied, 510 U.S. 1044, 114 S.Ct. 691 , 126 L.Ed.2d 658 (1994); see In re Agent Orange Product Liability Lit., 611 F.Supp. 1223, 1250 (E.D.N.Y.1985) (to prove specific causation, plaintiffs expert must first prove general causation and …
cited Cited "see" Saint Vincent Health Center v. Shalala
W.D. Pa. · 1995 · signal: see · confidence high
See id.
cited Cited "see" Good Samaritan Hospital Regional Medical Center v. Shalala
S.D.N.Y. · 1995 · signal: see · confidence high
See Albert Einstein Medical Ctr. v. Sullivan, 830 F.Supp. 846, 849 (E.D.Pa.1992), aff'd, 6 F.3d 778 (3d Cir.1993).
cited Cited "see" Daubert v. Merrell Dow Pharmaceuticals, Inc.
9th Cir. · 1995 · signal: see · confidence high
See DeLuca v. Merrell Dow Pharmaceuticals, Inc., 791 F.Supp. 1042, 1048 (D.N.J.1992), aff'd, 6 F.3d 778 (3d Cir.1993). .
discussed Cited "see" Daubert v. Merrell Dow Pharmaceuticals, Inc.
9th Cir. · 1995 · signal: see · confidence high
See DeLuca v. Merrell Dow Pharmaceuticals, Inc., 791 F.Supp. 1042, 1048 (D.N.J.1992), aff'd, 6 F.3d 778 (3d Cir.1993) 8 As Judge Frank Johnson has succinctly noted, "the examination of a scientific study by a cadre of lawyers is not the same as its examination by others trained in the field of science or medicine." Perry v. United States, 755 F.2d 888, 892 (11th Cir.1985) 9 There may well be good reasons why a scientific study has not been published.
discussed Cited "see" Wade-Greaux Ex Rel. Greaux v. Whitehall Laboratories, Inc.
D.V.I. · 1994 · signal: see · confidence high
See DeLuca by DeLuca v. Merrell Dow Pharmaceuticals, Inc., 911 F.2d 941 , 958 (3d Cir. 1990) (testimony must be able to support a jury finding both (i) that the drug can cause birth defects and (ii) that the drug more likely than not caused the birth defects in this particular case), on remand to 791 F. Supp. 1042 (D.N.J. 1992), aff'd, 6 F.3d 778 (3d Cir. 1993); see In re Agent Orange Product Liability Lit., 611 F. Supp. 1223, 1250 (E.D.N.Y. 1985) (to prove specific causation, plaintiff's expert witnesses must first prove general causation and then exclude other possible causes for the plainti…
cited Cited "see" Resolution Trust Corporation in Its Capacity as Receiver for Bell Federal Savings Bank v. John L. Daddona, Sr., Judy Daddona and Daniel Culnen
3rd Cir. · 1993 · signal: see · confidence high
See Bell Savings Bank v. CUL-DADD, 6 F.3d 778 (1993).
discussed Cited "see, e.g." 51 soc.sec.rep.ser. 278, Medicare & Medicaid Guide P 44,486, 97 Cal. Daily Op. Serv. 5104, 96 Daily Journal D.A.R. 8231 French Hospital Medical Center, a California Nonprofit Corporation v. Donna E. Shalala, in Her Official Capacity as Secretary of the United States Department of Health and Human Services
9th Cir. · 1996 · signal: see also · confidence low
See also Albert Einstein Medical Ctr. v. Sullivan, 830 F.Supp. 846, 848-49 (E.D.Pa.1992), aff'd, 6 F.3d 778 (3d Cir.1993) (in appealing revised NPR, provider may appeal only items the fiscal intermediary "examined or changed"); Delaware County Memorial Hosp. v. Sullivan, 836 F.Supp. 238, 245 (E.D.Pa.1991) (provider may appeal items that were under review in revised NPR).
discussed Cited "see, e.g." French Hospital Medical Center v. Shalala
9th Cir. · 1996 · signal: see also · confidence low
See also Albert Einstein Medical Ctr. v. Sullivan, 830 F.Supp. 846, 848-49 (E.D.Pa.1992), aff'd, 6 F.3d 778 (3d Cir.1993) (in appealing revised NPR, provider may appeal only items the fiscal intermediary “examined or changed”); Delaware County Memorial Hosp. v. Sullivan, 836 F.Supp. 238, 245 (E.D.Pa.1991) (provider may appeal items that were under review in revised NPR).
discussed Cited "see, e.g." Hca Health Services of Oklahoma, Inc. v. Donna E. Shalala, Secretary, Department of Health and Human Services
D.C. Cir. · 1994 · signal: see, e.g. · confidence low
See, e.g., Albert Einstein Medical Ctr. v. Sullivan, 830 F.Supp. 846 (E.D.Pa.19.92), aff'd, 6 F.3d 778 (3d Cir.1993); Delaware County Memorial Hosp. v. Sullivan, 836 F.Supp. 238 (E.D.Pa.1991); French Hosp.
Retrieving the full opinion text from the archive…
Di Gian (Robert)
v.
Clinton (William)
93-1123.
Court of Appeals for the Third Circuit.
Aug 30, 1993.
6 F.3d 778
Published

6 F.3d 778

Di Gian (Robert)
v.
Clinton (William)

NO. 93-1123

United States Court of Appeals,
Third Circuit.

Aug 30, 1993

Appeal From: E.D.Pa.,

Reed, J.

1

AFFIRMED.